These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25429537)

  • 1. [Antimicrobial properties of ceftaroline fosamil].
    Seifert H
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S85-6. PubMed ID: 25429537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Zinforo™ (ceftaroline fosamil)--A new beta-lactam-cephalosporin with MRSA activity].
    Welte T
    Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S89-90. PubMed ID: 25429539
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials.
    Shorr AF; Kollef M; Eckburg PB; Llorens L; Friedland HD
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):298-303. PubMed ID: 23357290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
    Mokuolu AO; Jiya N; Adesiyun OO
    Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of antimicrobial resistance.
    Virk A; Steckelberg JM
    Mayo Clin Proc; 2000 Feb; 75(2):200-14. PubMed ID: 10683663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.
    Taboada M; Melnick D; Iaconis JP; Sun F; Zhong NS; File TM; Llorens L; Friedland HD; Wilson D
    J Antimicrob Chemother; 2016 Apr; 71(4):862-70. PubMed ID: 26702925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection.
    Hautala T; Syrjälä H; Lehtinen V; Kauma H; Kauppila J; Kujala P; Pietarinen I; Ylipalosaari P; Koskela M
    Int J Antimicrob Agents; 2005 Apr; 25(4):329-33. PubMed ID: 15784313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
    Critchley IA; Eckburg PB; Jandourek A; Biek D; Friedland HD; Thye DA
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii45-51. PubMed ID: 21482569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
    Jandourek A; Smith A; Llorens L; Thye DA; Eckburg PB; Friedland HD
    Hosp Pract (1995); 2014 Feb; 42(1):75-8. PubMed ID: 24566599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of sputum gram stain and culture.
    Musher DM
    Arch Intern Med; 2005 Feb; 165(4):470-1. PubMed ID: 15738381
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceftaroline fosamil for community-acquired pneumonia.
    Pawluk SA; Wilby KJ
    Lancet Infect Dis; 2015 Sep; 15(9):999. PubMed ID: 26333321
    [No Abstract]   [Full Text] [Related]  

  • 13. Ceftaroline fosamil: drug profile and clinical data.
    Kanafani ZA
    Future Microbiol; 2011 Jan; 6(1):9-18. PubMed ID: 21162631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftaroline fosamil for community-acquired pneumonia--Authors' reply.
    Zhong NS; Sun T; Wilson D; Melnick D
    Lancet Infect Dis; 2015 Sep; 15(9):999-1000. PubMed ID: 26333322
    [No Abstract]   [Full Text] [Related]  

  • 15. Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy.
    DiMondi VP; Drew RH; Chen LF
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):567-72. PubMed ID: 21819323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.
    Lamb HM; Ormrod D; Scott LJ; Figgitt DP
    Drugs; 2002; 62(7):1041-89. PubMed ID: 11985490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of lower respiratory tract infections in elderly].
    Iakovlev SV
    Ter Arkh; 1997; 69(12):57-63. PubMed ID: 9503539
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microbiological study of nosocomial lung infections].
    Araque-Granadillo MC; Nieves-Blanco BM
    Rev Latinoam Microbiol; 1993; 35(2):147-52. PubMed ID: 8209107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Extended spectrum beta lactamase forming pathogens (ESBL)].
    Gastmeier P
    Med Klin Intensivmed Notfmed; 2012 Nov; 107(8):592-3. PubMed ID: 23138656
    [No Abstract]   [Full Text] [Related]  

  • 20. The choice of antibacterial drugs.
    Med Lett Drugs Ther; 1998 Mar; 40(1023):33-42. PubMed ID: 9549552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.